Molecularly targeted co-delivery of a histone deacetylase inhibitor and paclitaxel by lipid-protein hybrid nanoparticles for synergistic combinational chemotherapy-Reference-Cited by-同舟云学术

Molecularly targeted co-delivery of a histone deacetylase inhibitor and paclitaxel by lipid-protein hybrid nanoparticles for synergistic combinational chemotherapy

Published:2017-01-19 Issue:9 Volume:8 Page:14925-14940
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Ruttala Hima Bindu¹,Ramasamy Thiruganesh¹,Poudal Bijay Kumar¹,Choi Yongjoo¹,Choi Ju Yeon¹,Kim Jeonghwan¹,Ku Sae Kwang²,Choi Han-Gon³,Yong Chul Soon¹,Kim Jong Oh¹

Affiliation:

1. College of Pharmacy, Yeungnam University, 214-1, Dae-dong, Gyeongsan, 712-749, South Korea

2. College of Korean Medicine, Daegu Haany University, Gyeongsan, 712-715, South Korea

3. College of Pharmacy, Institute of Pharmaceutical Science and Technology, Hanyang University, Sangnok-gu, Ansan 426-791, South Korea

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Injectable dual thermoreversible hydrogel for sustained intramuscular drug delivery;Journal of Controlled Release;2024-10

2. Lipid- and Protein-based Nanodelivery Systems;Functional Materials from Lipids and Proteins;2024-08-23

3. Targeting the epigenome with advanced delivery strategies for epigenetic modulators;Bioengineering & Translational Medicine;2024-08-17

4. Anti-EGFR immunoliposomes for cabazitaxel delivery: From formulation development to in vivo evaluation in prostate cancer xenograft model;International Journal of Pharmaceutics;2024-08

5. Recent advances of novel targeted drug delivery systems based on natural medicine monomers against hepatocellular carcinoma;Heliyon;2024-01